Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)

Clinical trial NCT05130047 · COMPLETED

Trial details

NCT number: NCT05130047
Sponsor: Michael Camilleri, MD
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Diarrhea Irritable Bowel Syndrome With Diarrhea Bile Acid Malabsorption Bile Acid Diarrhea Bile Acid Malabsorption Syndrome Type II Functional Diarrhea

Start date: 2021-12-01
Primary completion: 2022-11-08
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.